AAAP Advanced Accelerator Applicatio

38.32
+1.60  (4%)
Previous Close 36.72
Open 36.94
Price To book 4.94
Market Cap 1.69B
Shares 43,976,000
Volume 90,951
Short Ratio 3.99
Av. Daily Volume 89,173

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 initiated September 2016
Apoptosis
Necrosis
Phase 2 initiated September 2016
Annexin V-128
Early Breast Cancer
Positive opinion by EMA released in October 2016.
Somakit-TOC
Neuroendocrine cancers
CRL issued December 21, 2016. Noted March 23, 2017 that NDA to be resubmitted mid-2017.
Lutathera
Inoperable progressive midgut NETs
Approved June 1, 2016.
Somakit-TATE
Neuroendocrine tumor diagnosis
Ongoing
Annexin V-128
Rheumatoid arthritis and ankylosing spondylitis

Latest News

  1. Advanced Accelerator Applications Receives 2017 Industry Innovation Award from National Organization for Rare Disorders for NETSPOT®, a Diagnostic Drug for Neuroendocrine Tumors
  2. ETFs with exposure to Advanced Accelerator Applications SA : May 1, 2017
  3. ETFs with exposure to Advanced Accelerator Applications SA : April 10, 2017
  4. Advanced Accelerator Applications SA :AAAP-US: Earnings Analysis: Q4, 2016 By the Numbers : April 7, 2017
  5. Advanced Accelerator Applications Signs Strategic Supply Agreement with University of Missouri for Lutetium 177
  6. Today's Strong Buys Breaking Out to New Highs
  7. Edited Transcript of AAAP earnings conference call or presentation 23-Mar-17 2:00pm GMT
  8. Advanced Accelerator Applications Reports 23% Sales Growth for Fiscal 2016; Continued NETSPOT® Launch Success
  9. Investor Network Invites You to the Advanced Accelerator Applications Year-End 2016 Earnings Conference Call and Webcast Live on Thursday, March 23, 2017
  10. Biotech firm says it’s closing in on the cancer that killed Steve Jobs
  11. Advanced Accelerator Applications to Announce Full-Year 2016 Financial Results on March 23
  12. Calithera Biosciences (CALA) Rises: Stock Moves Up 19.3%
  13. New Strong Buy Stocks for March 9th
  14. Advanced Accelerator Applications Announces Presentation of Quality of Life Findings from NETTER-1 Phase III Study at ENETS
  15. Advanced Accelerator Applications Announces Addition of NETSPOT® to National Comprehensive Cancer Network® Guidelines for Evaluation of NETs
  16. Advanced Accelerator (AAAP) Catches Eye: Stock Jumps 5.4%
  17. ETFs with exposure to Advanced Accelerator Applications SA : January 11, 2017